Lexicon Pharmaceuticals, Inc. (LXRX)

5.70
0.07 1.21
NASDAQ
Prev Close 5.77
Open 5.72
Day Low/High 5.61 / 5.82
52 Wk Low/High 4.26 / 13.97
Volume 148.70K
Exchange NASDAQ
Shares Outstanding 106.27B
Market Cap 620.63M
Div & Yield N.A. (N.A)
Lexicon Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q1 2012 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Presents At JP Morgan Healthcare Conference (Transcript)

Lexicon Pharmaceuticals' CEO Presents At JP Morgan Healthcare Conference (Transcript)

Lexicon Pharmaceuticals' CEO Presents at JP Morgan Healthcare Conference (Transcript)

7 Stocks Under $10 Moving Higher

7 Stocks Under $10 Moving Higher

When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits if you time your trade correctly.

Lexicon Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q3 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q2 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q2 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q2 2011 Results - Earnings Call Transcript

8 Health Care Stocks With Recent Gains

8 Health Care Stocks With Recent Gains

These stocks delivered attractive returns in the past month, outperforming the S&P Index as well as major peers.

Lexicon Pharmaceuticals' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals' CEO Discusses Q1 2011 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. CEO Discusses F4Q10 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. CEO Discusses F4Q10 Results - Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. CEO Discusses F4Q10 Results - Earnings Call Transcript

Lexicon Pharmaceuticals CEO Discusses Q3 2010 Results – Earnings Call Transcript

Lexicon Pharmaceuticals CEO Discusses Q3 2010 Results – Earnings Call Transcript

Lexicon Pharmaceuticals CEO Discusses Q3 2010 Results â¿¿ Earnings Call Transcript

Biotech Winners: Lexicon Pharma, Exelixis

Lexicon Pharmaceuticals and Exelixis shares are among the leading gainers in the biotech sector Monday.

Lexicon Pharmaceuticals Incorporated Q2 2010 Earnings Call Transcript

Lexicon Pharmaceuticals Incorporated Q2 2010 Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

Lexicon Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

eOn Communications, Compugen: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Tuesday's session.

Pacific Ethanol, Force Protection: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Monday's session.

Sirius XM, Lexicon Pharma: Early Volume Plays

Sirius XM, Lexicon Pharma: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Wednesday's session.

Sirius XM, Zagg: Early Volume Plays

Sirius XM, Zagg: Early Volume Plays

Several small-cap stocks were poised to move on above-average volume during Friday's session.

Monday's Late Winners & Losers

Movie Gallery falls hard.

Monday's Health Winners & Losers

Encysive falls hard on regulatory news.

Tuesday's Health Winners & Losers

Health care stocks were flat on mixed earnings Tuesday.

TheStreet Quant Rating: D- (Sell)